Marker Therapeutics Inc.
MRKR | NASDAQ
$1.20
+$0.02 (+1.69%)
At close: Sep 21, 2026, 4:00 PM ET
$1.20
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | 6.59M | 3.31M | 3.51M | 1.24M | 466.79K |
Cost of Revenue | n/a | 13.47M | 10.42M | 11.97M | 3.16M | 18.88M |
Gross Profit | n/a | -6.88M | -7.11M | -8.45M | -1.92M | -18.41M |
Operating Income | -12.89M | -11.12M | -14.58M | -19.79M | -39.48M | -28.89M |
Interest Income | 594.21K | 437.01K | 539.16K | 248.06K | 5.7K | 148.74K |
Pretax Income | -12.18M | -10.68M | -14.04M | -19.78M | -41.88M | -28.71M |
Net Income | -12.16M | -10.73M | -8.24M | -29.93M | -41.88M | -28.71M |
Selling & General & Admin | 4.18M | 4.24M | 7.48M | 11.34M | 9.76M | 10.47M |
Research & Development | 11.8M | 13.47M | 10.42M | 11.97M | 27.79M | 18.88M |
Other Expenses | -3.09M | -13.47M | -10.42M | -11.97M | n/a | -18.88M |
Operating Expenses | 12.89M | 4.24M | 7.48M | 11.34M | 37.56M | 10.47M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 12.89M | 17.71M | 17.89M | 23.3M | 40.72M | 29.35M |
Income Tax Expense | -15.16K | 49.95K | 3.68K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 15.31M | 8.98M | 8.81M | 8.35M | 7.65M | 4.7M |
Shares Outstanding (Diluted) | 15.31M | 8.98M | 8.81M | 8.35M | 7.65M | 4.7M |
EPS (Basic) | -0.79 | -1.19 | -1.93 | -3.58 | -5.47 | -6.10 |
EPS (Diluted) | -0.79 | -1.19 | -1.93 | -3.58 | -5.47 | -6.10 |
EBITDA | -12.44M | -10.68M | -11.25M | -16.99M | -38.72M | -27.63M |
EBIT | -12.44M | -10.68M | -14.04M | -19.78M | -41.88M | -28.71M |
Depreciation & Amortization | n/a | 2 | 2.79M | 2.79M | 3.16M | 1.08M |
Add to Watchlist
Select watchlists to add or remove MRKR